3285.4000 24.10 (0.74%)
NSE Sep 18, 2025 15:31 PM
Volume: 155.3K
 

3285.40
0.74%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Geojit BNP Paribas increased Hold price target of Dr. Lal Pathlabs Ltd. to 3548.0 on 02 Sep, 2025.
More from Dr. Lal Pathlabs Ltd.
Recommended